Citius Oncology, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CTOR | GUD.TO | 688321.SS | I7G.F | 300558.SZ | CTXR | |
|---|---|---|---|---|---|---|
| Market cap | 57.85M | 1.11B | 9.47B | 12.79B | 20.76B | 15.13M |
| P/E (TTM) | — | 75.3 | 133.7 | 25.1 | 77.9 | — |
| Forward P/E | — | 43.5 | -107.0 | — | 29.2 | -0.4 |
| Price/book | 1.4 | 1.4 | 3.7 | 2.7 | 3.2 | 0.2 |
| Dividend yield | — | — | 0.28% | 1.05% | 0.31% | — |
| 1-year change | −64.29% | +92.81% | −31.78% | +22.89% | −12.57% | −58.18% |
| Today | −0.55% | +0.36% | +2.84% | +2.04% | +1.62% | −3.87% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All CTOR news ›Citius Oncology's Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe
Nov 4, 2026 1:45pm EST Data featured in oral presentation at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) 2026 Annual Meeting in Berlin Patients who responded to LYMPHIR…
Analyzing Citius Oncology (CTOR) and Its Rivals
Posted by Defense World Staff on Oct 31st, 2026 Citius Oncology (NASDAQ:CTOR – Get Free Report) is one of 844 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare…
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
792 units purchased by U.S. wholesalers for the three months ended September 30, 2026, compared to 360 units for the three months ended June 30, 2026, an increase of 120%; 950 LYMPHIR vials ordered by prescribing centers from wholesalers…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- aol.com1
- defenseworld.net1
- prnewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.